Gerald Koelsch

Title: Innovations of Gerald Koelsch in Memapsin Research

Introduction

Gerald Koelsch is an accomplished inventor based in Oklahoma City, OK (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for memapsin 2, which is relevant for Alzheimer's disease treatment.

Latest Patents

Gerald Koelsch holds 2 patents, with his latest focusing on "Catalytically active recombinant memapsin and methods of use thereof." This patent details methods for producing purified, catalytically active recombinant memapsin 2. The research includes determining the substrate and subsite specificity of the enzyme, which has led to the design of substrate analogs that can inhibit memapsin 2's function. These analogs are based on peptide sequences related to natural substrates and contain amide bond analogs that cannot be cleaved by memapsin 2. The synthesis of two substrate analogues, OMR99-1 and OM99-2, was developed, with OM99-2 demonstrating an inhibition constant of 1.6×10 M against recombinant pro-memapsin 2. Crystallography studies have provided insights into the three-dimensional structure of the protein, aiding in the design of new inhibitors for diagnostic and therapeutic applications.

Career Highlights

Throughout his career, Gerald Koelsch has worked with notable institutions, including the Oklahoma Medical Research Foundation and the University of Illinois. His work has significantly advanced the understanding of memapsin 2 and its implications in Alzheimer's disease.

Collaborations

Gerald has collaborated with esteemed colleagues such as Lin Hong and Xinli Lin, contributing to the innovative research in his field.

Conclusion

Gerald Koelsch's work in the development of memapsin inhibitors showcases his dedication to advancing medical research and offers hope for Alzheimer's disease treatment. His contributions are invaluable to the scientific community and the ongoing fight against neurodegenerative diseases.